Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

APIs from the Algorithm

| Stephanie Vine | 2 min read

DRAGONFLY deep learning meets de novo drug design – and Roche has already tested the approach

Discovery & Development Drug Discovery

Combination Revelation

| Rob Coker | 2 min read

Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

Discovery & Development Drug Discovery

ADCs Versus Solid Tumors

| Stephanie Vine | 3 min read

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Discovery & Development Drug Discovery

Top Treatment Prospects: Alzheimer’s Disease

| Jamie Irvine | 9 min read

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Discovery & Development Drug Discovery

Advancements in the Fight Against Alzheimer's Disease

| Mallikarjun Chityala | 3 min read

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Discovery & Development Drug Discovery

Treating the Fentanyl Epidemic

| Andrew Barrett | 4 min read

How – and why – we are tackling opioid use disorder with a monoclonal antibody

Discovery & Development Drug Discovery

Understanding Drug Development for Women

| Stephanie Vine | 3 min read

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Discovery & Development Drug Discovery

Maurice Hilleman, We Salute You

| Rob Coker | 4 min read

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Discovery & Development Drug Discovery

Open Innovation Against Epilepsy

| Rob Coker | 2 min read

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy

Discovery & Development Translational Science

Finding Alternatives to Animal Testing

| 6 min read

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine